Uploaded image for project: 'eCQM Issue Tracker'
  1. eCQM Issue Tracker
  2. CQM-6102

CMS 506 medications during inpatient stay - not ordered at discharge

XMLWordPrintable

    • Icon: EH/CAH eCQMs - Eligible Hospitals/Critical Access Hospitals EH/CAH eCQMs - Eligible Hospitals/Critical Access Hospitals
    • Resolution: Answered
    • Icon: Moderate Moderate
    • None
    • None
    • Hide
      ​​Thank you for your question on Safe Use of Opioids - Concurrent Prescribing (CMS506v5). The measure only uses medications on the Medication, Discharge list to identify encounters for inclusion in the measure. Home medications (medications that the patient continues to take after discharge) and newly prescribed medications for use after discharge should be included on the Medication, Discharge list. You are correct that opioids and benzodiazepines administered only during the inpatient stay should not count towards inclusion in the measure, and the patient in your example should not be included in the measure.

      It sounds like the complication is that the opioid medication administered during the inpatient stay is not discontinued at discharge in the EHR system, but is discontinued in the system at some point after discharge. The measure intention is to use the Medication, Discharge list to identify patients that will be taking opioids or benzodiazepines after their inpatient stay, after the hospital clinician has reconciled medications for discharge.

      Please let us know if this answers your question.
      Show
      ​​Thank you for your question on Safe Use of Opioids - Concurrent Prescribing (CMS506v5). The measure only uses medications on the Medication, Discharge list to identify encounters for inclusion in the measure. Home medications (medications that the patient continues to take after discharge) and newly prescribed medications for use after discharge should be included on the Medication, Discharge list. You are correct that opioids and benzodiazepines administered only during the inpatient stay should not count towards inclusion in the measure, and the patient in your example should not be included in the measure. It sounds like the complication is that the opioid medication administered during the inpatient stay is not discontinued at discharge in the EHR system, but is discontinued in the system at some point after discharge. The measure intention is to use the Medication, Discharge list to identify patients that will be taking opioids or benzodiazepines after their inpatient stay, after the hospital clinician has reconciled medications for discharge. Please let us know if this answers your question.
    • CMS0506v5
    • Placing cases erroneously in the measure population

      Our eCQM report captured ‘Ativan injection 2mg/1ml’ but discharge summary or other EHR sources didn’t indicate this was ordered as discharge medication. Patient didn’t go home with the medication. This was not even home medication. MD ordered the medication as PRN while patient was in inpatient stay only. Our EHR IT response was that Ativan was ordered and authorized during the encounter and wasn’t discontinued before the encounter ended.  That's why QRDA captured the medication. Is this mapping correct??  I think medications that are ordered as inpatient medications shouldn’t be just mapped in QRDA without MD new order at discharge.

            JLeflore Joelencia Leflore
            skim1566 so yeon kim (Inactive)
            Votes:
            0 Vote for this issue
            Watchers:
            3 Start watching this issue

              Created:
              Updated:
              Resolved:
              Solution Posted On: